Low Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis.

We demonstrate that markedly reduced dose IV MTP with a lower overall cumulative dose GC is safe and effective in the management of severe AAV disease, with no significant difference in primary outcomes.